رجوع
نطاق اليوم
KWD 3.27
KWD 3.35
نطاق 52 أسبوعًا
KWD 1.89
KWD 6.52
حجم التداول
2,045,398
متوسط 50 يوم / 200 يوم
KWD 3.62
/
KWD 4.10
الإغلاق السابق
KWD 3.36
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -6.9 | 0.3 |
| P/B | 0.9 | 2.9 |
| ROE % | -13.3 | 3.7 |
| Net Margin % | -194.9 | 3.8 |
| Rev Growth 5Y % | -33.1 | 10.0 |
| D/E | 0.1 | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 20.170
+509.4%
Low: KWD 5.000
High: KWD 34.000
ربحية السهم المستقبلية
-KWD 0.647
الإيرادات المقدّرة
30 M
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2030 |
-KWD 0.590
-KWD 1.170 – -KWD 0.335
|
120 M | 1 |
| FY2029 |
-KWD 0.745
-KWD 1.478 – -KWD 0.423
|
72 M | 1 |
| FY2028 |
-KWD 0.780
-KWD 0.851 – -KWD 0.647
|
55 M | 3 |
النقاط الرئيسية
Revenue declined -33.11% annually over 5 years
Debt/Equity of 0.13 — conservative balance sheet
Negative free cash flow of -174.07M
PEG of 0.64 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 193.67%
Capital intensive — 56.93% of revenue goes to capex
النمو
Revenue Growth (5Y)
-33.11%
Revenue (1Y)160.56%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
-13.33%
ROIC-12.68%
Net Margin-194.88%
Op. Margin-288.98%
الأمان
Debt / Equity
0.13
Current Ratio11.32
Interest Coverage0.00
التقييم
P/E Ratio
-6.85
P/B Ratio0.88
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 160.56% | Revenue Growth (3Y) | 40.56% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -33.11% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 75.13M | Net Income (TTM) | -146.41M |
| ROE | -13.33% | ROA | -10.79% |
| Gross Margin | 100.00% | Operating Margin | -288.98% |
| Net Margin | -194.88% | Free Cash Flow (TTM) | -174.07M |
| ROIC | -12.68% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.13 | Current Ratio | 11.32 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -6.85 | P/B Ratio | 0.88 |
| P/S Ratio | 13.36 | PEG Ratio | 0.64 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.00B | Enterprise Value | 991.66M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 75.13M | 28.83M | 38.03M | 485.42M | 375.20M |
| Net Income | -146.41M | -162.86M | -146.40M | 158.52M | 153.46M |
| EPS (Diluted) | -0.49 | -0.55 | -0.51 | 0.50 | 0.48 |
| Gross Profit | 75.13M | 28.83M | 38.03M | 418.99M | 329.69M |
| Operating Income | -217.10M | -314.77M | -237.21M | 216.51M | 204.41M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.36B | 1.36B | 1.49B | 1.54B | 1.32B |
| Total Liabilities | 215.59M | 304.47M | 335.78M | 307.63M | 292.84M |
| Shareholders' Equity | 1.14B | 1.06B | 1.15B | 1.23B | 1.03B |
| Total Debt | 143.22M | 65.36M | 77.38M | 82.26M | 40.07M |
| Cash & Equivalents | 155.01M | 156.33M | 133.32M | 386.54M | 476.14M |
| Current Assets | 728.23M | 751.37M | 871.99M | 1.03B | 929.80M |
| Current Liabilities | 64.31M | 76.61M | 119.01M | 118.32M | 120.68M |